title: Treatment of mania in children and adolescents.
abstract: Bipolar disorder (BPD) is a severe and complex illness that seriously disrupts the lives of those afflicted. Increased rates of suicide attempts and completions, poorer academic performances, disturbed interpersonal relationships, increased rates of substance abuse, legal difficulties, and multiple hospitalizations all have been associated with BPD. At least 1% of children and adolescents have this disorder. This commentary is designed to review and summarize the recent literature on the treatment of manic and/or hypomanic phases of BPD in children and adolescents.
authors.affiliation: Drexel College of Medicine, Philadelphia, PA 19124, USA. rsheikh@drexelmed.edu
authors.forename: Roomana
authors.initials: R
authors.lastname: Sheikh
authors.forename: Joon
authors.initials: J
authors.lastname: Kang
authors.forename: Ronald
authors.initials: R
authors.lastname: Weller
authors.forename: Elizabeth B
authors.initials: EB
authors.lastname: Weller
mesh_terms: D000293:Adolescent; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D002220:Carbamazepine / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D006801:Humans; D018020:Lithium Compounds / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D014635:Valproic Acid / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D018692:Antimanic Agents; D014150:Antipsychotic Agents; D018020:Lithium Compounds; D002220:Carbamazepine; D014635:Valproic Acid